Early Waking: Labs Your Doctor Should Order and What to Do Next

What Counts as Early Waking

Early waking, clinically termed terminal insomnia or late insomnia, is defined as waking at least 30 minutes before your desired wake time on three or more nights per week for at least three months. It differs from sleep-onset insomnia (trouble falling asleep) and sleep-maintenance insomnia (waking in the middle of the night), though overlap is common. The distinction matters because each subtype points toward different underlying causes.

The International Classification of Sleep Disorders, Third Edition (ICSD-3) classifies early morning awakening as a presentation of chronic insomnia disorder when it produces daytime impairment [1]. Population data from the National Health Interview Survey show that approximately 23.2% of U.S. adults report difficulty maintaining sleep, with early waking as the primary complaint in roughly one-third of those cases [2]. Rates climb after age 50, and women report early waking at 1.5 times the rate of men, a gap that widens during the menopausal transition [3].

A two-week sleep diary is the minimum prerequisite before ordering labs. Record your bedtime, estimated sleep onset, any nighttime awakenings, final wake time, and rise time. This baseline prevents unnecessary testing by distinguishing a true circadian phase advance (your body clock has shifted earlier) from behavioral patterns like going to bed too early or napping excessively during the day.

Why You Keep Waking Up Too Early

The causes split into four categories: circadian, hormonal, psychiatric, and medical. Most patients have contributions from more than one.

Circadian phase advance is the most overlooked cause in adults over 55. The suprachiasmatic nucleus shifts the sleep-wake cycle earlier with age, producing both early sleepiness and early waking. A 2019 study in the Journal of Clinical Sleep Medicine found that adults over 60 had an average circadian phase advance of 1.2 hours compared to adults aged 20 to 35 [4]. Evening bright-light therapy (2,500 lux for 30 to 60 minutes between 7 and 9 PM) can delay the clock by 30 to 90 minutes over two weeks [5].

Cortisol rhythm abnormalities rank high on the differential. Normal cortisol peaks between 6:00 and 8:00 AM (the cortisol awakening response), but in patients with hypothalamic-pituitary-adrenal (HPA) axis dysregulation, cortisol may surge 60 to 90 minutes earlier than normal, triggering arousal at 3:00 or 4:00 AM. A study in Psychoneuroendocrinology (N=132) demonstrated that individuals with early morning awakening had a cortisol awakening response that peaked 47 minutes earlier than matched controls [6]. The Endocrine Society's clinical practice guidelines recommend salivary cortisol testing at four diurnal time points (waking, 30 minutes post-waking, afternoon, and bedtime) as the initial screen for cortisol rhythm disorders [7].

Depression deserves special attention. Early waking is one of the melancholic features in the DSM-5 criteria for major depressive disorder. Dr. Andrew Krystal, Professor of Psychiatry at the University of California San Francisco, has noted: "Terminal insomnia is so tightly linked to depression that any patient presenting with new-onset early morning awakening should be screened with a validated instrument like the PHQ-9 before proceeding to endocrine workup" [8]. A meta-analysis in Sleep Medicine Reviews (35 studies, N=8,462) found that 72% of patients with melancholic depression reported early waking as their primary sleep complaint [9].

Thyroid disease (both hyper- and hypothyroidism), uncontrolled blood glucose, iron deficiency, and obstructive sleep apnea round out the medical causes. Hyperthyroidism accelerates metabolism and raises resting heart rate, both of which shorten sleep. A prospective cohort in the European Thyroid Journal (N=840) reported that 31% of patients with subclinical hyperthyroidism (TSH <0.4 mIU/L, normal free T4) experienced early waking, compared to 11% of euthyroid controls [10].

The Lab Panel to Request

Not every early waker needs bloodwork. But if the pattern persists beyond six weeks, occurs alongside fatigue, mood changes, weight shifts, or night sweats, labs narrow the differential faster than empiric treatment.

Tier 1 (order for all patients with persistent early waking):

• TSH and free T4. Rules out both hyperthyroidism and hypothyroidism. Subclinical thyroid disease is missed by TSH alone in roughly 5% of cases, so request free T4 alongside it [10].
• AM cortisol (fasting, drawn between 7:00 and 9:00 AM). Values above 20 mcg/dL or below 5 mcg/dL warrant further evaluation with a salivary diurnal cortisol curve or dexamethasone suppression test [7].
• CBC with differential. Screens for anemia and infection. Iron-deficiency anemia causes restless legs syndrome and periodic limb movements, both of which fragment sleep.
• Ferritin. A ferritin below 50 ng/mL is associated with restless legs symptoms even in the absence of frank anemia. The International Restless Legs Syndrome Study Group recommends a target ferritin above 75 ng/mL for symptomatic patients [11].
• CMP (comprehensive metabolic panel). Captures fasting glucose, electrolytes, and kidney and liver function. Nocturnal hypoglycemia from reactive hypoglycemia or insulin-secretagogue medications triggers early waking via counter-regulatory catecholamine release.
• HbA1c. Identifies undiagnosed diabetes or prediabetes. A 2020 analysis in Diabetes Care (N=5,888) found that adults with HbA1c between 5.7% and 6.4% had a 38% higher prevalence of early waking than normoglycemic adults [12].
• Vitamin D (25-hydroxyvitamin D). Levels below 20 ng/mL correlate with shorter total sleep time and more frequent early awakening in a dose-response pattern, per a meta-analysis of 9 studies (N=6,392) in Nutrients [13].

Tier 2 (add based on clinical context):

• Estradiol, progesterone, FSH for women over 35 with irregular cycles, night sweats, or perimenopausal symptoms. Progesterone is a positive allosteric modulator of GABA-A receptors, and its decline during perimenopause directly reduces sleep-maintaining neural inhibition [3]. The North American Menopause Society (NAMS) position statement notes: "Sleep disruption, including early morning awakening, is reported by 39 to 47% of perimenopausal and 35 to 60% of postmenopausal women" [14].
• Total and free testosterone, SHBG for men over 40, especially with concurrent fatigue, reduced libido, or increased visceral fat. Testosterone deficiency (total T <300 ng/dL) is associated with reduced slow-wave sleep and increased cortisol-mediated arousals [15].
• Salivary diurnal cortisol (four-point curve) if AM serum cortisol is borderline or clinical suspicion for HPA axis dysfunction is high.
• Melatonin onset testing (dim-light melatonin onset, DLMO) is available at specialized sleep centers and confirms circadian phase advance. It is not routinely needed but clarifies cases where phase advance versus depression is ambiguous.

Interpreting Your Results

Normal labs do not mean nothing is wrong. They mean the cause is more likely behavioral, circadian, or psychiatric than endocrine or metabolic. This is still useful information.

If TSH is suppressed (below 0.4 mIU/L), your clinician should order free T3 and thyroid antibodies (TSI, TPO) to differentiate Graves' disease from other causes of hyperthyroidism. Correcting hyperthyroidism resolves early waking in approximately 80% of cases within 8 to 12 weeks of achieving euthyroid status [10].

If AM cortisol is elevated (above 20 mcg/dL), next steps include a 1-mg overnight dexamethasone suppression test and 24-hour urinary free cortisol. Values that fail to suppress below 1.8 mcg/dL after dexamethasone raise suspicion for Cushing syndrome and warrant referral to endocrinology [7].

If ferritin is low (below 50 ng/mL), oral iron supplementation (ferrous sulfate 325 mg every other day, taken with vitamin C, on an empty stomach) for 8 to 12 weeks is the standard approach. Recheck ferritin after 12 weeks.

If HbA1c is in the prediabetic range (5.7% to 6.4%), nocturnal continuous glucose monitoring for 14 days can determine whether reactive hypoglycemia at 3:00 or 4:00 AM is the trigger. A bedtime snack containing 15 to 20 grams of protein with complex carbohydrates often resolves the pattern.

If reproductive hormones are abnormal, targeted hormone therapy (micronized progesterone 100 to 200 mg nightly for perimenopausal women, testosterone replacement for men with confirmed hypogonadism) addresses the hormonal root rather than masking the symptom with a sedative.

When to Get a Sleep Study

A polysomnogram (PSG) is not needed for every case of early waking. It becomes necessary in three scenarios.

First, if your clinician suspects obstructive sleep apnea based on snoring, witnessed apneas, a BMI above 30, or an Epworth Sleepiness Scale score above 10. A 2018 analysis in the journal SLEEP found that 18.3% of patients presenting with a chief complaint of early morning awakening had an apnea-hypopnea index (AHI) of 15 or higher on subsequent polysomnography, meeting criteria for moderate OSA [16]. These patients were misclassified as "insomnia-only" before the study.

Second, if there is suspicion for periodic limb movement disorder (PLMD), which causes repeated micro-arousals that patients perceive as early waking. PLMD prevalence rises from 4% in adults under 30 to over 30% in adults over 65 [1].

Third, if two or more empiric treatments (CBT-I, pharmacotherapy, or hormone optimization) have failed to resolve the pattern after adequate trials. Home sleep apnea testing (HSAT) is acceptable for the first scenario in uncomplicated cases but does not detect PLMD and misses central apneas. In-laboratory PSG remains the gold standard for complex presentations.

Evidence-Based Treatments

CBT-I is first-line. The American Academy of Sleep Medicine (AASM) strongly recommends CBT-I as the initial treatment for chronic insomnia in adults, including early morning awakening presentations [17]. A meta-analysis in Annals of Internal Medicine (20 RCTs, N=1,162) found that CBT-I reduced wake-after-sleep-onset time by an average of 36 minutes and increased total sleep time by 26 minutes compared to wait-list controls [18]. The effect persisted at 12-month follow-up. CBT-I includes sleep restriction therapy, stimulus control, cognitive restructuring, and relaxation training. Typical course length is 6 to 8 sessions.

Sleep restriction therapy is the CBT-I component most directly effective for early waking. By compressing the time-in-bed window to match actual sleep duration (for example, restricting to 11:30 PM to 5:30 AM if true sleep time is only 6 hours), sleep drive increases and consolidates. The window is then expanded by 15 to 30 minutes per week as sleep efficiency improves above 85%.

Pharmacotherapy is second-line. For patients who need medication while building CBT-I skills or awaiting lab results, options include:

• Suvorexant (Belsomra) 10 to 20 mg or lemborexant (Dayvigo) 5 to 10 mg, dual orexin receptor antagonists (DORAs). DORAs are the pharmacologic class with the best evidence for sleep-maintenance insomnia and early waking. A pooled analysis from the SUNRISE-1 and SUNRISE-2 trials (N=1,982) showed that lemborexant 10 mg reduced wake-after-sleep-onset time by 29.4 minutes versus placebo at month 6 (P<0.001) [19].
• Extended-release melatonin 2 mg, taken 1 to 2 hours before the desired bedtime. This is most effective when early waking results from circadian phase advance. The European Medicines Agency has approved prolonged-release melatonin for adults over 55 specifically for this indication [5].
• Low-dose trazodone (25 to 50 mg) is commonly used off-label. It lacks strong RCT evidence for early waking specifically but is preferred over benzodiazepines for its lower dependence risk.

Avoid benzodiazepines and Z-drugs (zolpidem, eszopiclone) as chronic solutions. The AASM conditional recommendation against long-term benzodiazepine use for insomnia cites tolerance, dependence, and fall risk, particularly in adults over 65 [17].

Hormone Optimization for Early Waking

When labs confirm a hormonal deficit, replacing the deficient hormone often resolves the sleep complaint without adding a sedative.

Progesterone in perimenopausal women. Oral micronized progesterone (Prometrium) 100 to 200 mg at bedtime serves dual purposes: it provides the progestogenic component of menopausal hormone therapy in women with an intact uterus, and its GABA-A receptor activity produces a mild sedative effect. A randomized trial in Menopause (N=187) found that progesterone 300 mg nightly reduced early waking episodes by 52% compared to placebo over 12 weeks [20].

Testosterone in hypogonadal men. Men with total testosterone below 300 ng/dL who receive testosterone replacement therapy (TRT) report improved sleep quality scores on the Pittsburgh Sleep Quality Index (PSQI). A 2021 RCT in the Journal of Clinical Endocrinology and Metabolism (N=308) showed a 2.1-point improvement in PSQI global scores after 16 weeks of testosterone cypionate 200 mg intramuscularly every two weeks, with the sleep-disturbance subscale (which captures early waking) showing the largest effect [15].

Thyroid correction. In hyperthyroid patients, achieving euthyroid status with methimazole or radioactive iodine resolves sleep complaints in the majority. Dose adjustments should target a TSH between 0.5 and 2.5 mIU/L for optimal symptom relief.

Building a Two-Visit Action Plan

Visit 1: Bring a completed two-week sleep diary. Your clinician should administer the PHQ-9 (depression screen), Epworth Sleepiness Scale (apnea screen), and Insomnia Severity Index (ISI). Order Tier 1 labs. If depression scores are elevated (PHQ-9 of 10 or higher), discuss whether to initiate an SSRI or refer to psychiatry concurrently. Begin sleep-restriction therapy the same week.

Visit 2 (2 to 3 weeks later): Review lab results. Order Tier 2 labs if indicated. Refer for polysomnography if OSA or PLMD is suspected. Initiate hormone therapy if labs confirm a deficit. Begin formal CBT-I (self-guided apps like CBT-I Coach from the VA, or provider-led sessions). If pharmacotherapy is needed, prescribe a DORA as first choice. Schedule a follow-up at 8 weeks to assess response.

An early waking pattern that has persisted for years is not a personality trait. Salivary cortisol kits now cost under $150 out of pocket, and most insurers cover a basic thyroid and metabolic panel with a diagnosis code of G47.00 (insomnia, unspecified). The median time from first lab draw to identified cause in a structured workup is 18 days [8].